DRI Latest Quotes, Charts & Stock Information

Home » DRI

Latest Insights on DRI

G-20 Weekend: 4 Things You Need to Know June 28, 2019 by Joseph Hargett Great Stuff It’s G-20 weekend! Aren’t you excited? World leaders are gathering in Osaka, Japan, to discuss how best to take advantage of each other and you, the investor. It’s kind of like Family Feud, except on a global scale. For a closer look at this growing kerfuffle, here’s your Friday Four Play: Russian President Vladimir Putin […]

Copper Stocks Are Set to Surge This Year June 28, 2019 by Anthony Planas American Investor Today, Investment Opportunities, Natural Resources The threat of a global trade war, an economic slowdown and a bear market for metals have caused copper prices to remain low. But Anthony Planas sees low copper prices as an opportunity to profit from the inevitable surge in copper stocks this year. (2-minute read)

Bitcoin’s Crypto Bubble, Thanks to Facebook Libra June 27, 2019 by Joseph Hargett Great Stuff Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]

ROBO ETF Is a Great Way to Invest in the Emerging Tech Revolution June 27, 2019 by Charles Mizrahi American Investor Today, Investment Opportunities, Technology Electricity changed the world forever. It would be very difficult for our modern society to exist without it. Nowadays, there is a new trend that’s already changing our way of living. Charles Mizrahi has a close eye on this profitable sector. (3-minute read)

The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]